|
Volume 272, Number 29,
Issue of July 18, 1997
pp. 17987-17993
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Insulinotropic Glucagon-like Peptide-1-mediated Activation of
Non-selective Cation Currents in Insulinoma Cells Is Mimicked by
Maitotoxin*
(Received for publication, June 4, 1996, and in revised form, May 15, 1997)
Colin A.
Leech
and
Joel F.
Habener
From the Laboratory of Molecular Endocrinology, Howard Hughes
Medical Institute, Harvard Medical School, Massachusetts General
Hospital, Boston, Massachusetts 02114
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES
ABSTRACT
Maitotoxin (MTX) activates a
Ca2+-dependent non-selective cation
current (ICa-NS) in insulinoma cells whose time course is
identical to non-selective cation currents activated by incretin
hormones such as glucagon-like peptide-1 (GLP-1), which stimulate
glucose-dependent insulin secretion by activating cAMP
signaling pathways. We investigated the mechanism of activation of
ICa-NS in insulinoma cells using specific pharmacological
reagents, and these studies further support an identity between MTX-
and GLP-1-activated currents. ICa-NS is inhibited by
extracellular application of genistein, econazole, and SKF 96365. This
inhibition by genistein suggests that tyrosine phophorylation may play
a role in the activation of ICa-NS. ICa-NS is
not inhibited by incubation of cells in glucose-free solution, by
extracellular tetrodotoxin, nimodipine, or tetraethylammonium, or by
intracellular dialysis with 4-aminopyridine, ATP, ryanodine, or
heparin. ICa-NS is also not significantly inhibited by
staurosporine, which does, however, partially inhibit the MTX-induced
rise of intracellular Ca2+ concentration. These effects of
staurosporine suggest that protein kinase C may not be involved in the
activation of ICa-NS but that it may regulate intracellular
Ca2+ release. Alternatively, ICa-NS may have a
small component that is carried through separate divalent
cation-selective channels that are inhibited by staurosporine.
ICa-NS is neither activated nor inhibited by dialysis with
KF, KF + AlF3 or GTP S (guanosine 5 -O-(3-thiotriphosphate)), suggesting that GTP-binding
proteins do not play a major role in the activation of this
current.
INTRODUCTION
The consensus model of glucose-stimulated insulin secretion is
that closure of ATP-sensitive K+ channels
(K+ATP)1 permits
membrane depolarization, activation of voltage-dependent Ca2+ channels (VDCCs) and the influx of Ca2+
(1). Individual -cells, however, are often unresponsive to glucose
alone, but can become responsive by combined stimulation with glucose
and hormones, such as insulinotropic hormone glucagon-like peptide-1
(GLP-1; Ref. 2), that elevate intracellular cAMP levels (3-5). One
mechanism underlying this increased responsiveness is the enhanced
closure of K+ATP channels (2). A second
mechanism by which GLP-1, pituitary adenylate cyclase-activating
polypeptide (PACAP), and cAMP can induce -cell depolarization is
through the activation of voltage-independent, non-selective cation
currents (6, 7). Similar cation currents are also activated by MTX, a
polyether toxin isolated from dinoflagellates that in -cells has
been shown to stimulate insulin secretion and inositol trisphosphate
(Ins(1,4,5)P3) production (8) and to enhance the influx of
monovalent cations (9).
MTX-sensitive currents are activated by depletion of intracellular
Ca2+ stores (10), and GLP-1 enhances intracellular
Ca2+ mobilization through the potentiation of
ryanodine-sensitive Ca2+-induced Ca2+ release
in TC3 cells (11, 12). Increased cAMP levels stimulate Ca2+ release from secretory granules and reduce
mitochondrial Ca2+ uptake in -cells (13, 14). These
observations raise the possibility that the activation of non-selective
cation currents by PACAP and GLP-1 may be a secondary consequence of
glucose- and cAMP-dependent intracellular Ca2+
release. The physiological role of Ca2+ release-activated
currents in -cells remains controversial, but such currents have
been suggested to play a role in the cholinergic modulation of
electrical bursting activity (15), and may control the membrane
potential and intracellular Ca2+
([Ca2+]i) oscillations in response to nutrient
stimulation (10).
Both PACAP (16) and GLP-1 (17) are potent insulin secretagogues in the
presence of slightly elevated glucose levels. The activation of a
voltage-independent, non-selective cation current by these hormones
under conditions that stimulate insulin secretion suggests that this
current may play an important role in depolarizing -cells to
initiate insulin secretion. The aim of this study is to examine the
mechanism of activation of the MTX-sensitive current and to compare the
properties of ICa-NS with the current activated by GLP-1,
PACAP, and cAMP to determine whether these currents are likely to be
carried through the same channels.
MATERIALS AND METHODS
Preparation of Cell Cultures
HIT-T15 cells were obtained
from the American Type Culture Collection. TC6 cells were obtained
from Dr. Shimon Efrat (Albert Einstein College of Medicine, New York,
NY). HIT-T15 cells (passages 67-75) were maintained in Ham's F-12
medium containing 10 mM glucose, 10% heat-inactivated
horse serum, and 2.5% fetal bovine serum. TC6 cells (passages
24-59) were maintained in Dulbecco's modified Eagle's medium
containing 25 mM glucose, 15% horse serum, and 2.5% fetal
bovine serum. Culture media also contained 100 units/ml penicillin G
and 100 µg/ml streptomycin. Cells were plated onto glass coverslips
coated with 1 mg/ml of type V concanavalin A (Sigma), which facilitates
their adherence to glass. Cultures were maintained at 37 °C in a 5%
CO2 atmosphere incubator, and experiments were
conducted 1-5 days post-plating.
Test Solutions
Cells were bathed in a standard
extracellular solution (SES) containing: 138 mM NaCl, 5.6 mM KCl, 2.6 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES (295 mosM; pH adjusted to 7.4 with NaOH, approximately 4 mM), and 0.8 mM D-glucose unless
indicated as being different in the text. Na+-free,
N-methyl-D-glucamine (NMG) solutions were
prepared using 138 mM NMG substituted for NaCl and adjusted
to pH 7.4 with HCl. A Na+-free, 100 Ca solution was also
prepared containing: 100 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES (282 mosM; pH adjusted to 7.4 with KOH, approximately 6 mM) Other test solutions were prepared by substitution of
NaCl with 140 mM KCl, CsCl, LiCl, or choline chloride.
Ca2+-free solutions were prepared by substituting
MgCl2 or MnCl2 for CaCl2. Low
[Cl ]o solution was prepared by substituting
NaCl with Na-aspartate.
Test solutions containing MTX were applied to individual cells by focal
application from micropipettes using a PicoSpritzer II pressure
ejection system (General Valve, Fairfield, NJ). A gravity-fed bath
superfusion system was used to exchange and refresh bath solutions.
Maitotoxin, econazole, staurosporine, nimodipine, and glyburide were
obtained from Sigma. Tetrodotoxin, SKF 96365, genistein, GTP S,
ryanodine, and heparin were obtained from Calbiochem. Tetraethylammonium chloride (TEA) and 4-aminopyridine (4AP) were obtained from Aldrich.
Measurement of Intracellular Calcium
Cells were prepared
for measurement of [Ca2+]i by incubation in
fura-2 acetoxymethyl ester (fura-2 AM; Molecular Probes, Inc., Eugene,
OR). Cells were loaded in SES supplemented with 2% fetal bovine serum,
0.03% pluronic F-127, and 1 µM fura-2 AM for 15 min at
room temperature (20-22 °C). Coverslips with fura-loaded adherent
cells formed the base of a recording chamber mounted on a
temperature-controlled stage (Micro Devices, Jenkintown, PA).
Cells were visualized using a Zeiss IM35 microscope equipped with
a Nikon UVF100 100× objective. Measurements of
[Ca2+]i were performed at 1-s intervals from the
average of 10 video frames using a dual excitation wavelength video
imaging system (IonOptix Corp., Milton, MA). Experiments were conducted at 32 °C. [Ca2+]i was estimated from the ratio
of 510 nm emission fluorescences due to excitation by 350 nm and 380 nm
wavelength light from the following equation (18).
|
(Eq. 1)
|
Kd is the dissociation constant of fura-2
(225 nM), is the ratio of 380 nm induced fluorescences
of free/bound fura-2, R is the measured ratio of 350 nm/380
nm fluorescences and Rmin and
Rmax are 350 nm/380 nm fluorescence ratios in
zero [Ca2+] and saturating [Ca2+],
respectively. Values of , Rmin, and
Rmax were determined using fura-2 pentapotassium
salt and calibration solutions from Molecular Probes, Inc.
Patch Clamp Recording Techniques
Cell resting potentials
and membrane currents were measured under current clamp or voltage
clamp using either whole-cell or perforated patch configurations (19,
20). Patch pipettes pulled from borosilicate glass (Kimax-51, tip
resistance 2-4 megohms) were fire polished and tip-dipped in K- or
Cs-pipette solution containing: 95 mM
K2SO4 (or Cs2SO4), 7 mM MgCl2, 5 mM HEPES (pH adjusted
to 7.4 with NaOH; final concentration of Na+ approximately
2 mM). Pipettes were then back-filled with the same
solution, to which nystatin (240 µg/ml) was added for perforated patch recording.
The patch pipette was connected to an Heka Electronik EPC-9 patch clamp
amplifier (Instrutech Corp., Mineola, NY) interfaced with a Macintosh
Quadra 840AV computer running Pulse version 8.0 software (Instrutech
Corp.). The series resistance (Rs) and cell capacitance (Cm) were monitored following seal
formation, and experiments were conducted when
Rs declined to <35 megohms. In voltage clamp
experiments, Rs was compensated for by 60%.
Values are given as mean ± S.E. Statistical significance was
determined using Student's t test computed using Lotus
1-2-3 spreadsheets.
RESULTS
MTX activates a non-selective cation current in TC6 cells (Fig.
1) that has a reversal potential of -7.8 ± 1.0 mV
(n = 72) in SES (142 mM
[Na+]o). This current was observed in all cells
tested, and its reversal potential becomes more negative as
[Na+]o is reduced (Fig. 1, Table
I), although the shift is less than predicted from the
Nernst potential for Na+. ICa-NS is also
observed in solutions where extracellular Na+ is replaced
by Cs+, K+, Li+,
choline+, or NMG+ and in cells dialyzed with
K+, Cs+, Na+, choline+,
or NMG+ with Na+ in the bathing solution (Table
II), confirming the non-selective nature of this
current. Changing from normal [Cl ]o to low
[Cl ]o extracellular solution did not affect the
amplitude or reversal potential of the current (data not shown),
confirming the cation selectivity of ICa-NS.
Fig. 1.
MTX activates a non-selective cation current
mainly carried by Na+. Panel A shows the whole
cell current from a perforated patch (Cs-pipette solution)
voltage-clamped TC6 cell (Cm 11.3 pF) initially bathed
in SES (142 mM Na+). All bath solutions
contained 5 mM TEA, 2 µM TTX, and 100 µM Cd2+ (to inhibit
Ca2+-activated K+ channels,
voltage-dependent Na+ channels, and VDCCs
respectively). Breaks in the trace (labeled 1-6) mark where series of
four voltage ramps from 70 mV to +30 mV (1 V/s) were applied.
Currents were filtered at 1 kHz. A 2-s pulse of 10 pM MTX
was applied (arrow) and the bath solution subsequently changed to 14 mM Na+ (Tris-HCl-substituted),
returned to SES, exchanged with 14 mM Na+
(NMG-substituted), and again returned to SES as indicated. Panel B shows the averaged currents from series of voltage ramps (as indicated in A) before MTX (1), after MTX stimulation (2), and after changing the bath to 14 mM Na+ (3).
Panel C shows the currents from the ramp series subtracted as indicated. The reversal potential of the MTX-activated current in
this cell was 0 mV in 142 mM Na+ and reversibly
shifted to 31 mV in 14 mM Na+ (Table I). The
currents during ramp series (5) were too small to allow accurate
determination of the reversal potential.
[View Larger Version of this Image (36K GIF file)]
It is reported that Ca2+ is impermeant through
MTX-activated channels in mouse -cells (10) in contrast with a
report that Ca2+ is permeant through such channels in mouse
L-cells (21). We therefore decided to re-examine the Ca2+
permeability of ICa-NS. Ca2+ influx through
MTX-sensitive channels in HIT-T15 cells is suggested by an increase of
[Ca2+]i when hyperpolarizing voltage steps are
applied following activation of the MTX-sensitive current and by the
rapid and reversible fall of [Ca2+]i when
extracellular Ca2+ is removed (Figs. 2 and
3A). Fig. 2 shows that a hyperpolarizing voltage clamp step
from 70 mV to 100 mV had no effect on [Ca2+]i
in a HIT-T15 cell before stimulation with MTX, but that similar voltage
steps applied after activation of ICa-NS resulted in a
pronounced increase of [Ca2+]i that was
reversibly abolished by removal of extracellular Ca2+.
Hyperpolarizing pulses applied following activation of non-selective cation currents by GLP-1 (22) or 8-bromo-cAMP (7) also increased [Ca2+]i.
Fig. 2.
Hyperpolarizing voltage steps increase
[Ca2+]i following MTX stimulation. Fig. 2
shows simultaneous records of membrane current (top trace)
and [Ca2+]i (lower trace) from a
HIT-T15 cell (Cm 14.0 pF) held initially at 70 mV in
perforated patch voltage clamp. Membrane potential is shown as the
inset. The cell was bathed in 0.8 mM glucose SES
plus 1 µM TTX and was dialyzed with Cs-pipette solution. A 15-s hyperpolarizing step to 100 mV before stimulation with MTX
produces a small increase in the holding current and no detectable increase of [Ca2+]i. The cell was then stimulated
with 25 pM MTX (indicated by bar), and a step
from 70 mV to 100 mV following MTX produces an increase in the
holding current and a reversible rise of [Ca2+]i.
The bath solution was then changed to a Ca2+-free
(Mg2+-substituted + 50 µM EGTA + 1 µM TTX) solution resulting in a decrease of
[Ca2+]i and inhibition of the
hyperpolarization-induced increase of [Ca2+]i. On
return to SES (2.6 mM Ca2+),
[Ca2+]i increases and hyperpolarization again
produces a further rise of [Ca2+]i.
[View Larger Version of this Image (18K GIF file)]
Fig. 3.
Effects of removing extracellular
Ca2+ on membrane currents and changes in
[Ca2+]i. Panel A shows simultaneous
recordings of membrane current (top trace) and
[Ca2+]i (lower trace) from a TC6
cell (Cm 23.5 pF) bathed in SES and held at 70 mV in
perforated patch voltage clamp using K-pipette solution. Bath perfusion
with Ca2+-free solution (50 µM EGTA,
indicated by bar) produces a small reduction of
[Ca2+]i from 138 nM to 118 nM and a small increase in the holding current, these
effects are reversed by perfusion with SES. A 10-s pulse of 50 pM MTX induces an inward current and rise of
[Ca2+]i. The rise of
[Ca2+]i was rapidly and reversibly reduced by
bath perfusion with Ca2+-free solution (bar).
ICa-NS was slightly reduced by the Ca2+-free
solution in this cell. The TC6 cell shown in B
(Cm 7.7 pF) was bathed in SES plus 5 mM TEA, 1 µM TTX, and 1 µM nimodipine and was held at
70 mV using Cs-pipette solution. An inward current developed, and
[Ca2+]i fell from 52 nM to 41 nM during bath perfusion with Ca2+-free
solution (50 µM EGTA plus TEA, TTX, and nimodipine,
indicated by bar). The reversal potential of the current was
estimated from voltage ramps (r, data not shown) to be 13
mV. The current rapidly inactivates when SES is reintroduced into the
bath and [Ca2+]i increases to 95 nM.
A subsequent pulse of 50 pM MTX (30 s, starting at
arrow) activates an inward current (reversal potential 12
mV) and a rise in [Ca2+]i. Panel C
shows that activation of ICa-NS increases Mn2+
quenching of intracellular fura-2 fluorescence. This HIT-T15 cell
(Cm 38.8 pF) was bathed in SES plus 5 mM TEA, 1 µM TTX, and 1 µM nimodipine and was held at
70 mV using Cs-pipette solution. Application of a 60-s pulse of
Ca2+-free, Mn2+-substituted solution before MTX
produces a gradual quenching of fura-2 fluorescences (i and
ii), a small increase in the holding current
(iii) similar to that seen in panel A,
i, with little change in the fluorescence ratio
(iv). Stimulation with MTX (1-s pulse, arrow)
activates the inward current and rise in [Ca2+]i,
and a subsequent 60-s pulse of the Ca2+-free,
Mn2+-substituted solution produces rapid quenching of
fura-2 fluorescence (i and ii) and a fall in
[Ca2+]i (iv) with little effect on
membrane current (iii).
[View Larger Version of this Image (36K GIF file)]
We further tested the effects of removal of extracellular
Ca2+ to confirm the activation of MTX-sensitive currents by
Ca2+-free solutions (10) and to determine the effects of
activation of the current on [Ca2+]i in the
absence of extracellular Ca2+. In 15/18 cells tested, bath
perfusion with a Ca2+-free solution containing 50 µM EGTA (the Ca2+ concentration in this
solution was measured (using K5 fura-2) to be 150 nM) before stimulation with MTX caused a small, reversible increase of the membrane current and a fall of
[Ca2+]i (Fig. 3A).
Holding currents at 70 mV increased from 0.96 ± 0.16 pA/pF in
SES to 1.64 ± 0.30 pA/pF (p = 0.005) and [Ca2+]i decreased from 117 ± 15 nM to 99 ± 15 nM on removal of
extracellular Ca2+ (not statistically significant,
p = 0.4). In 3/18 cells the holding current showed a
much larger increase on transfer to Ca2+-free solution
(Fig. 3B). The holding current in these cells increased by
21.8 ± 4.3 pA/pF and [Ca2+]i reduced from
75 ± 15 nM to 37 ± 4 nM
(p = 0.1). This current inactivates rapidly, and
[Ca2+]i is transiently elevated when SES (2.6 mM Ca2+) is reintroduced to the bath (Fig.
3B). Elevation of [Ca2+]i and
activation of a non-selective cation current were also observed in a
similar subset of cells following stimulation with thapsigargin (2-10
µM, data not shown), as reported previously (10).
Bath perfusion with Ca2+-free solution after the activation
of ICa-NS results in a rapid, reversible fall of
[Ca2+]i but has only a small effect on the
current amplitude (Figs. 2 and 3A). The reversal potential
of the MTX-activated current in Ca2+-free solution is
10.1 ± 2.8 mV (n = 12), not significantly
different (p = 0.43) from the reversal potential
measured in SES. These data suggest that Ca2+-influx
carries only a small proportion of the current through MTX-sensitive
channels in the presence of Na+. However, the rapid and
reversible effects of removing extracellular Ca2+ on
[Ca2+]i suggests that ICa-NS does
permit Ca2+ entry.
Further evidence for the influx of divalent cations through
MTX-sensitive channels is suggested by increased Mn2+
quenching of intracellular fura-2 fluorescence following
MTX-stimulation (Fig. 3C). Fig. 3C (i
and ii) shows the raw fura-2 fluorescence emission values,
application of a 60-s pulse of Ca2+-free,
Mn2+-substituted solution before stimulation with MTX
produces a gradual quenching of the fluorescence signals, a small
increase in the holding current (Fig. 3C, iii),
and little or no change in the 350 nm/380 nm fluorescence ratio (Fig.
3C, iv). Following activation of the inward
current and rise in [Ca2+]i, a pulse of
Ca2+-free, Mn2+-substituted solution produces
rapid quenching of fura-2 fluorescence (Fig. 3C,
i and ii) with little or no effect on membrane
current (Fig. 3C, iii) and reduces the
fluorescence ratio (Fig. 3C, iv), consistent with
a decrease in [Ca2+]i. Similar activation of
Mn2+ quenching has been observed following stimulation of
insulinoma cells with PACAP (6), cAMP (22), and thapsigargin (23, 24).
A role for Ca2+ influx through MTX-sensitive channels is
further supported by the effects of applying high
[Ca2+]o solutions. A Na+-free test
solution containing 100 mM Ca2+ was applied to
a TC6 cell prior to stimulation with MTX and produces a small
increase of [Ca2+]i (Fig. 4),
similar to the effects of applying elevated [Ca2+]o solutions to mouse islets (25).
Application of 100 mM [Ca2+]o
solution following stimulation with MTX produces a pronounced
inhibition of ICa-NS (Fig. 4) and a negative shift in the
reversal potential of the current (Table I). This inhibition of
ICa-NS by the 100 mM Ca2+ solution
is accompanied by a rise of [Ca2+]i (Fig. 4).
These data could be explained by Ca2+ influx through a
single class of non-selective cation channel with a lower permeability
to Ca2+ than to Na+ under these experimental
conditions. Alternatively, ICa-NS may have two (or more)
components, one component being monovalent cation selective, and the
other, smaller, component being selective for divalent cations.
Fig. 4.
Na+-free, 100 mM
Ca2+ solutions decrease ICa-NS and raise
[Ca2+]i. A TC6 cell (Cm 28.7 pF) was held at 70 mV in perforated patch voltage clamp with
Cs-pipette solution and SES plus 5 mM TEA, 1 µM TTX, and 10 µM nimodipine. The bath
solution was then exchanged with Na+-free, 100 mM Ca2+, and this solution caused a gradual
increase of [Ca2+]i (lower trace) with
no apparent effect on the membrane current (upper trace).
The bath was then returned to SES and [Ca2+]i
recovered. A 1-s pulse of MTX (arrow) elicited an inward
current and a rise of [Ca2+]i. The bath solution
was then exchanged with Na+-free, 100 mM
Ca2+ and the current was inhibited, but
[Ca2+]i increased further. Bath perfusion with
SES again led to recovery of the current and a fall of
[Ca2+]i, indicating that the MTX-sensitive,
non-selective cation channels are permeant to Ca2+. The
reversal potential of the current shifted in the hyperpolarizing direction in Na+-free, 100 mM Ca2+
solution (Table I).
[View Larger Version of this Image (19K GIF file)]
The non-selective cation current activated by 8-bromo-cAMP in HIT-T15
cells is inhibited by whole cell dialysis with Ca2+-free,
EGTA-buffered solutions or by loading the cells with BAPTA (1,2-bis(2-aminophenoxy)ethane N,N,N ,N -tetraacetic acid),
a Ca2+ chelator (7) leading us to test the dependence of
ICa-NS activation on [Ca2+]i (Fig.
5). Whole cell recordings from HIT-T15 cells were
performed with either normal K-pipette solution (nominally Ca2+-free) or the same solution with 5 mM EGTA
added (Ca2+-free). Whole cell dialysis with
Ca2+-free intracellular solution inhibited activation of
ICa-NS compared with control cells from the same platings
dialyzed with nominally Ca2+-free solution or compared with
cells in perforated patch voltage clamp (Fig. 5). These observations
suggest that physiological [Ca2+]i levels are
required for activation of the current. It is notable that dialysis of
the cells with Ca2+-free solution does not induce
activation of the current alone, whereas dialysis with this solution
might be expected to deplete intracellular Ca2+ stores and
thus activate store-operated currents.
Fig. 5.
Activation of the MTX-sensitive current is
dependent upon intracellular Ca2+. Bar graph of
MTX-induced current amplitudes (inverted scale) in HIT cells held at
70 mV in perforated patch (perf., n = 5) or whole cell recording dialyzed with nominally Ca2+-free
(WCR, n = 5) and Ca2+-free (+ 5 mM EGTA, n = 6) K-pipette solutions. Whole
cell recording currents are not significantly different from perforated
patch current amplitudes (p = 0.39), whereas
calcium-free currents (EGTA) are significantly inhibited
compared with whole cell recording currents (p = 0.003).
[View Larger Version of this Image (31K GIF file)]
Ca2+-activated non-selective cation (Ca-NS) channels are
expressed in -cells that are activated at cytosolic
[Ca2+] > 10 4 M and are blocked
by 1 mM ATP and also by 10 mM 4AP when applied to the cytosolic face of isolated, inside-out patches (26, 27). Activation of ICa-NS is observed with physiological
[Ca2+]i levels but inhibition of the current by
dialysis of cells with Ca2+-free solutions suggests that it
may be carried through Ca-NS channels. To test this possibility, TC6
cells were bathed in glucose-free SES with 5 mM TEA and 10 nM glyburide added (to block Ca2+-activated
K+ channels and K+ATP channels) and
dialyzed in the whole cell recording mode with K-pipette solution and
10 mM 4AP either with or without 2 mM ATP. MTX-induced currents in cells dialyzed without ATP had a mean peak
amplitude of 23.6 ± 7.9 pA/pF (n = 6), and
cells from the same platings dialyzed with 2 mM ATP had
peak amplitudes of 22.5 ± 7.5 pA/pF (n = 6, not
significantly different, p = 0.9). These data indicate
that activation of ICa-NS is not
glucose-dependent, consistent with previous reports of
MTX-stimulated, glucose-independent insulin secretion (28). These
differences in the sensitivity of ICa-NS to
[Ca2+]i and to block by ATP and 4AP in whole cell
recordings compared with inside-out patches may indicate that
ICa-NS is not carried through the Ca-NS channels reported
previously (26, 27) or may reflect the different recording
configurations.
The non-selective cation current activated by PACAP in TC6 cells is
inhibited by SKF 96365 (22), a blocker of depletion-activated currents
(29) that inhibits MTX-induced Ca2+ influx and insulin
secretion (30). Fig. 6 shows that application of 50 µM SKF 96365 reversibly inhibits ICa-NS in
TC6 cells, similar to its effect on the PACAP-induced current in
these cells (22), further supporting the suggestion that these currents
are carried by the same channel type.
Fig. 6.
Inhibition of ICa-NS by SKF
96365. A TC6 cell (Cm 8.0 pF) was held at 70 mV
in perforated patch voltage clamp with Cs-pipette solution and bathed
in SES. A 1-s pulse of 50 pM MTX was applied
(arrow) and elicited an inward current. 50 µM
SKF 96365 was then applied (indicated by bar) by pressure
ejection from a pipette positioned close to the cell. SKF 96365 caused a reversible inhibition of the MTX-activated current in 8 cells tested.
[View Larger Version of this Image (15K GIF file)]
The activation of Mn2+ quenching of intracellular fura-2
fluorescence by MTX (Fig. 3C) is similar to that observed
following thapsigargin treatment of insulinoma cells (23, 24).
Thapsigargin-sensitive Ca2+ pools can also be depleted by
econazole, which inhibits Ca2+-ATPases (31) and thereby
elevates [Ca2+]i and also inhibits
Mn2+ quenching in HIT cells (23). We therefore tested the
effect of econazole on the activation of ICa-NS. Fig.
7A shows that 10 µM econazole
significantly reduces the amplitude of ICa-NS compared with
control cells from the same platings. The basal (pre-MTX) [Ca2+]i rose from 52 ± 7 nM to
182 ± 41 nM (n = 5, p = 0.01) in the presence of econazole and the peak amplitude of
ICa-NS decreased from 12.6 ± 2.3 pA/pF to
3.6 ± 1.1 pA/pF (n = 5, p = 0.01). The rise of [Ca2+]i above basal during the
MTX response was reduced from 449 ± 206 nM to 49 ± 14 nM (p = 0.09) by econazole.
Fig. 7.
Effects of inhibitors on ICa-NS
and the associated rise of [Ca2+]i. Panel
A shows normalized ICa-NS amplitudes (left panel, inverted scale) in TC6 cells held at 70 mV in
perforated patch voltage clamp (K-pipette solution). Control currents
(Cont., n = 5) were obtained from cells
bathed in SES, 10 µM econazole was then added to the bath
solution (Econ., n = 5), and currents from
the same platings of cells recorded in this solution. Econazole produced a significant reduction in the current amplitude
(p = 0.01), and the rise of
[Ca2+]i was also reduced (p = 0.09). Panel B shows control ICa-NS amplitudes
(left panel, inverted scale, n = 6) and
ICa-NS after addition of 100 µM genistein
(genis., n = 8) to the bath solution.
Genistein produces a significant reduction in current amplitude
(p = 0.01). The equivalent reduction of the change of [Ca2+]i is shown in the right panel
(p = 0.06). Panel C (left panel)
shows control ICa-NS amplitudes (inverted scale,
n = 5) and ICa-NS amplitudes following
addition of 1 µM staurosporine (Stauro.) to
the bath solution. Staurosporine had no significant effect on
ICa-NS current amplitudes (p = 0.9)
but significantly reduced the rise of [Ca2+]i
(p < 0.001, right panel).
[View Larger Version of this Image (44K GIF file)]
The effect of genistein, a tyrosine kinase inhibitor, on the activation
of ICa-NS was tested as capacitative Ca2+
influx activated by thapsigargin can also be inhibited by genistein (Ref. 32, Fig. 7B). The peak amplitude of ICa-NS
reduces from 20.2 ± 3.3 pA/pF (n = 6) in
control cells to 8.2 ± 2.6 pA/pF (n = 8, p = 0.01) following exposure of cells from the same
platings to 100 µM genistein. Basal
[Ca2+]i (pre-MTX) is not significantly affected
by genistein (88 ± 12 nM in control cells, 118 ± 19 nM in genistein, p = 0.2), while the
peak rise of [Ca2+]i during MTX responses reduced
from 1026 ± 388 nM (control) to 313 ± 92 nM (genistein, p = 0.06).
Protein kinase C (PKC) activates capacitative Ca2+ entry in
rat insulinoma (RINm5F) cells, and this activation of Ca2+
entry can be blocked by 1 µM staurosporine (24). We
therefore tested the effects of 1 µM staurosporine on
membrane currents and on the rise of [Ca2+]i
following MTX stimulation of TC6 cells (Fig. 7C). Staurosporine had no significant effect on ICa-NS; the mean
peak amplitude of control currents was 54.2 ± 19.5 pA/pF
(n = 5) compared with 51.1 ± 7.7 pA/pF
(n = 6, p = 0.9) in cells from the same platings after addition of 1 µM staurosporine to the
bathing solution. The pre-MTX basal [Ca2+]i in
control cells was 61 ± 11 nM and 96 ± 15 nM in cells bathed in staurosporine (p = 0.1), whereas the peak rise (increase above basal levels) of
[Ca2+]i was reduced from 1653 ± 252 nM to 142 ± 28 nM (p < 0.001) by staurosporine.
Activation of some types of non-selective cation current has been shown
to be mediated by GTP-binding proteins (33). We therefore examined the
potential role of GTP-binding proteins in the activation of
ICa-NS by dialysis of TC6 cells with Cs-pipette solution
supplemented with 10 mM 4AP, 2 mM
Na2ATP, and either 10 mM KF, 10 mM
KF + 100 µM AlF3, or 100 µM
GTP S. The bath contained SES with 5 mM TEA and 1 µM TTX. Whole cell dialysis of cells for 15-20 min with
KF (n = 4), KF + AlF3 (n = 5), or GTP S (n = 5) failed to activate inward
currents in cells that all subsequently responded to stimulation with
MTX (data not shown).
MTX stimulates an increase in Ins(1,4,5)P3 levels in
-cell lines (8), and this increase might activate ICa-NS
through an intracellular Ca2+ release mechanism. Heparin is
a specific blocker of Ins(1,4,5)P3 receptors that should
inhibit activation of ICa-NS if
Ins(1,4,5)P3-gated Ca2+ stores play an
important role. TC6 cells were dialyzed in whole cell recordings
with Cs-pipette solution plus 10 mM 4AP, 2 mM Na2ATP, and 0.5 mg/ml heparin for 3-4 min before
stimulation with MTX. Activation of ICa-NS was not
inhibited in cells dialyzed with heparin. The amplitude of the currents
was not significantly different from that in control cells from the
same platings, and the reversal potential of the currents was
7.0 ± 2.0 mV (n = 9), not significantly
different from control values (p = 0.96).
GLP-1 enhances intracellular Ca2+ mobilization from
ryanodine-sensitive stores in TC3 cells, and ryanodine reduces the
amplitude of [Ca2+]i spikes produced by
depolarizing voltage clamp steps within 1 or 2 min (11). We introduced
100 µM ryanodine into TC6 cells by whole cell dialysis
in the Cs/4AP/ATP-pipette solution (as above) and allowed 3-4 min
dialysis before stimulation with MTX. Ryanodine failed to prevent
activation of ICa-NS under these conditions, and the
current amplitude and reversal potential (-8.0 ± 1.9 mV,
n = 5) are not significantly different from control cells (p = 0.97).
DISCUSSION
We propose that MTX activates the same non-selective cation
current as stimulation with the peptide hormones GLP-1 and PACAP (6, 7,
22). These hormones couple through GTP-binding proteins (G-proteins) to
activate adenylyl cyclase and elevate intracellular cAMP in -cells
(3-5), and cAMP analogs can also activate these non-selective cation
currents. However, activation of G-proteins, by dialysis of cells with
KF, KF + AlF3, or GTP S (compounds that stimulate
G-protein mediated activation of non-selective cation currents in
epithelial cells (33) and activate K+ATP
channels in RINm5F and HIT-T15 insulinoma cells (34, 35)), neither
activated nor inhibited the MTX-sensitive current.
Depletion of intracellular Ca2+ stores activates a
MTX-sensitive current in mouse -cells (10), and the stimulation of
Ins(1,4,5)P3 production by MTX (8) raises the possibility
that Ins(1,4,5)P3-gated stores may play a role in the
activation of this current. Parasympathetic, cholinergic stimulation of
-cells stimulates Ins(1,4,5)P3 production, potentiates
glucose-induced insulin secretion (36), and also activates a
TTX-insensitive Na+-dependent depolarizing
current (37) that may also be carried through Ca2+
release-activated non-selective cation channels (15). The role of
intracellular Ca2+ release in the activation of this
current has, however, been disputed, and cholinergic activation of this
Na+ current is reported to be mediated by
M3-type muscarinic receptors being coupled to
Na+ channels (38). We observed that dialysis with heparin,
a blocker of Ins(1,4,5)P3 receptors, failed to inhibit
activation of ICa-NS, suggesting that Ca2+
release from these stores may not be critical.
The presence of a Ca2+ store depletion-activated current in
pancreatic -cells was proposed from studies showing: 1) that the state of filling of endoplasmic reticulum stores could regulate the
membrane potential in mouse -cells (39), 2) that thapsigargin can
activate Mn2+ quenching of intracellular fura-2 in RINm5F
cells (24), and 3) that the Mn2+ quenching pathway is
inhibited by econazole in HIT-T15 cells (23). Activation of
ICa-NS by thapsigargin and its inhibition by both econazole
and SKF 96365 are consistent with the suggestion that
ICa-NS may represent a Ca2+ release-activated
current (10, 31).
A role for PKC in the activation of store-operated Ca2+
entry in RINm5F cells was suggested from observations that the
sustained [Ca2+]i rise in response to combined
stimulation with PKC-activating phorbol esters and thapsigargin is
inhibited by staurosporine (24). We observed that staurosporine reduced
the MTX-induced [Ca2+]i rise but did not
significantly inhibit the amplitude of ICa-NS, suggesting
that PKC may not play a direct role in the activation of
ICa-NS but does regulate [Ca2+]i
responses. Such effects could be mediated through inhibition of
Ca2+ release from intracellular Ca2+ stores, or
could reflect the inhibition of a small, divalent cation selective
component of ICa-NS carried through a distinct set of
channels other than the non-selective cation channels. The high
concentration of staurosporine (1 µM) used in these
experiments would also be expected to inhibit
cAMP-dependent protein kinase, and further studies are
required to elucidate the role(s) of PKC and cAMP-dependent
protein kinase in the pathway(s) leading to the activation of
ICa-NS and regulation of [Ca2+]i
changes.
Inhibition of both ICa-NS and the MTX-induced
[Ca2+]i rise by genistein, an inhibitor of
tyrosine kinases (40) that blocks thapsigargin- and carbachol-induced
Ca2+ entry (32, 41), suggests a role for tyrosine
phosphorylation in the activation pathway of ICa-NS.
However, the role of tyrosine phosphorylation remains ambiguous as only
certain tyrosine kinase inhibitors (including genistein) effectively
block capacitative Ca2+ entry (42). Thapsigargin-induced
Ca2+ entry can also occur in the absence of detectable
tyrosine phosphorylation but is still inhibited by tyrosine kinase
inhibitors (43), and, therefore, the role of tyrosine kinases in
activation of ICa-NS remains to be clarified.
Ca-NS channels are expressed in -cells that are activated at
cytosolic [Ca2+] > 10 4 M (26,
27). Activation of ICa-NS is observed at physiological [Ca2+]i (approximately 100 nM) and is
inhibited by dialysis of cells with Ca2+-free solution,
similar to the inhibition of cAMP-activated currents (7) and suggesting
a Ca2+-dependent step in the activation pathway
of these channels. Ca-NS channels are also expressed in pancreatic
acinar cells, and these channels are activated at much lower cytosolic
Ca2+ concentrations in whole cell records than in isolated
patches (44); a similar difference in Ca2+ sensitivity
seems likely to occur for Ca-NS channels in -cells. Ca-NS channels
are blocked by 1 mM ATP and by 10 mM 4AP when
applied to the intracellular face of isolated membrane patches (27); however, these two compounds did not inhibit ICa-NS when
introduced into the cytosol by whole cell dialysis (at 2 mM
and 10 mM, respectively). It remains to be determined
whether these differences in sensitivity to
[Ca2+]i, 4AP, and ATP are a consequence of the
different recording conditions or suggest that Ca-NS channels do not
carry ICa-NS.
Reducing extracellular [Cl ] has no effect on
ICa-NS amplitude or on its reversal potential, confirming
the cation selectivity of the channel. Depletion of intracellular ATP
levels through bathing cells in glucose-free media and dialyzing with
ATP-free solutions or dialysis of cells with 2 mM ATP has
no effect on ICa-NS amplitudes. This further distinguishes
the MTX-induced current from the non-selective anion current described
in insulin-secreting cells that increases in amplitude upon dialysis
with 2 mM ATP (45).
Elevation of [Ca2+]i is observed following the
activation of non-selective cation currents by MTX, GLP-1, or PACAP in
voltage clamped cells where activation of voltage-dependent Ca2+ channels is prevented (6, 7, 22). This rise of
[Ca2+]i is reversed by removal of extracellular
Ca2+, suggesting that Ca2+ influx is associated
with the non-selective current, although it remains to be determined
whether a single class of channel is permeant to both monovalent and
divalent cations, or if two (or more) distinct conductances are
involved. The physiological role of Ca2+ influx associated
with ICa-NS in the stimulation of insulin secretion remains
to be determined. It has been reported that sustained Ca2+
influx through L-type VDCCs is strongly coupled to insulin secretion from HIT-T15 cells, whereas more transient Ca2+ influx
through N-type Ca2+ channels is only weakly coupled (46).
The Ca2+ influx associated with ICa-NS is
prolonged and may, therefore, be able to contribute to the sustained
[Ca2+]i elevation that triggers secretion.
However, the magnitude of this Ca2+ influx is likely to be
small compared with that through L-type channels as, under
physiological conditions, the cells will depolarize to a value close to
that for the reversal potential of ICa-NS, and also influx
through L-type VDCCs raises [Ca2+]i very rapidly,
whereas the [Ca2+]i increase associated with
ICa-NS develops much more slowly. This slow time course of
the rise in [Ca2+]i is consistent with a small
amplitude Ca2+ influx and would explain why it is difficult
to resolve a decrease in ICa-NS amplitude on changing to
Ca2+-free solution with normal extracellular
Na+ concentrations. It therefore seems that the main
physiological role for these non-selective cation currents in the
control of insulin secretion will be to depolarize the membrane
potential and activate VDCCs.
The currents activated by GLP-1, PACAP, cAMP analogs, and MTX are
Ca2+-dependent non-selective cation currents
that activate over tens of seconds and persist for extended periods
following removal of the stimulus. These currents are all insensitive
to TTX, L-type Ca2+ channel blockers, TEA, and ryanodine
but are inhibited by NMG, SKF96365, and La3+. Based upon
these similarities between the temporal properties of the currents, and
their associated [Ca2+]i changes, and the
pharmacology of the currents, we propose that these agents activate the
same non-selective cation channels. The precise mechanism(s)
controlling the activation of these non-selective cation channels
remains to be determined, but a role for tyrosine kinase-induced
phosphorylation is suggested by the effects of genistein. Activation of
ICa-NS may also be controlled by the state of filling of
intracellular Ca2+ stores, or may be partly due to
Ca2+ release from intracellular stores raising cytosolic
Ca2+ levels. We propose that activation of MTX-sensitive
non-selective cation channels may play an important role in
depolarizing -cells in response to stimulation by GLP-1 and PACAP
during feeding to initiate insulin secretion without large elevations
of blood glucose. We also suggest that Ca2+ is permeant
through the MTX-sensitive channels and suggest that spontaneous
activity of these channels may form the depolarizing, non-selective
background conductance that permits Ca2+ influx (25) and
opposes the activity of ATP-sensitive K+ channels in
regulating the resting potential of -cells under both basal
conditions and in response to hormonal stimulation.
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 617-726-5191;
Fax: 617-726-6954; E-mail: leech{at}helix.mgh.harvard.edu.
1
The abbreviations used are:
K+ATP, ATP-sensitive K+ channel;
MTX, maitotoxin; ICa-NS,
Ca2+-dependent non-selective cation current
activated by MTX and GLP-1; VDCCs, voltage-dependent
Ca2+ channels; GLP-1, glucagon-like peptide-1; PACAP,
pituitary adenylyl cyclase-activating polypeptide; TTX,
tetrodotoxin; NMG, N-methyl-D-glucamine; [X]i, intracellular concentration of ion
X (where X is any ion);
[X]o, extracellular concentration of ion
X; Ca-NS, Ca2+-activated non-selective
cation channel; Ins(1,4,5)P3, inositol 1,4,5-trisphosphate;
PKC, protein kinase C; GTP S,
guanosine-5 -O-(3-thiotriphosphate) tetralithium salt; SES,
standard extracellular solution; TEA, tetraethylammonium chloride;
4AP, 4-aminopyridine; pA, picoamps; pF, picofarads.
ACKNOWLEDGEMENT
We thank Maurice Castonguay for maintenance of
cell cultures.
REFERENCES
-
Ashcroft, F. M., and Rorsman, P.
(1991)
Prog. Biophys. Mol. Biol.
54,
87-143
[CrossRef]
-
Holz, G. G., Kuhtreiber, W. M., and Habener, J. F.
(1993)
Nature
361,
362-365
[CrossRef][Medline]
[Order article via Infotrieve]
-
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., and Habener, J. F.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
3434-3438
[Abstract/Free Full Text]
-
Gefel, D., Hendrick, G. K., Mojsov, S., Habener, J. F., and Weir, G. C.
(1990)
Endocrinology
126,
2164-2168
[Abstract/Free Full Text]
-
Thorens, B.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
8641-8645
[Abstract/Free Full Text]
-
Leech, C. A., Holz, G. G., and Habener, J. F.
(1995)
Endocrinology
136,
1530-1536
[Abstract]
-
Holz, G. G., IV, Leech, C. A., and Habener, J. F.
(1995)
J. Biol. Chem.
270,
17749-17757
[Abstract/Free Full Text]
-
Soergel, D. G., Gusovsky, F., Yasumoto, T., and Daly, J. W.
(1990)
J. Pharmacol. Exp. Ther.
255,
1360-1365
[Abstract/Free Full Text]
-
Murata, M., Gusovsky, F., Yasumoto, T., and Daly, J. W.
(1992)
Eur. J. Pharmacol.
227,
43-49
[CrossRef][Medline]
[Order article via Infotrieve]
-
Worley, J. F., III, McIntyre, M. S., Spencer, B., and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
32055-32058
[Abstract/Free Full Text]
-
Gromada, J., Dissing, S., Bokvist, K., Renstrom, E., Frokjaer-Jensen, J., Wulff, B. S., and Rorsman, P.
(1995)
Diabetes
44,
767-774
[Abstract]
-
Gromada, J., Rorsman, P., Dissing, S., and Wulff, B. S.
(1995)
FEBS Lett.
373,
182-186
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hahn, H. J., Gylfe, E., and Hellman, B.
(1980)
Biochim. Biophys. Acta
630,
425-432
[Medline]
[Order article via Infotrieve]
-
Wolters, G. H. J., Pasma, A., Wiegman, J. B., and Konijnendijk, W.
(1984)
Diabetes
33,
409-414
[Abstract]
-
Bertram, R., Smolen, P., Sherman, A., Mears, D., Atwater, I., Martin, F., and Soria, B.
(1995)
Biophys. J.
68,
1-10
-
Yada, T., Sakurada, M., Ihida, K., Nakata, M., Murata, F., Arimura, A., and Kikuchi, M.
(1994)
J. Biol. Chem.
269,
1290-1293
[Abstract/Free Full Text]
-
Fehmann, H. C., Goke, R., and Goke, B.
(1995)
Endocr. Rev.
16,
390-410
[Abstract/Free Full Text]
-
Grynkiewicz, G., Poenie, M., and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450
[Abstract/Free Full Text]
-
Horn, R., and Marty, A.
(1988)
J. Gen. Physiol.
92,
145-159
[Abstract/Free Full Text]
-
Leech, C. A., and Holz, G. G.
(1994)
Methods Cell Biol.
40,
135-151
[Medline]
[Order article via Infotrieve]
-
Estacion, M., Nguyen, H. B., and Gargus, J. J.
(1996)
Am. J. Physiol.
270,
C1145-C1152
[Abstract/Free Full Text]
-
Leech, C. A., Holz, G. G., and Habener, J. F.
(1996)
Ann. N. Y. Acad. Sci.
805,
81-93
[Medline]
[Order article via Infotrieve]
-
Leech, C. A., Holz, G. G., and Habener, J. F.
(1994)
Endocrinology
135,
365-372
[Abstract]
-
Bode, H. P., and Goke, B.
(1994)
FEBS Lett.
339,
307-311
[CrossRef][Medline]
[Order article via Infotrieve]
-
Silva, A. M., Rosario, L. M., and Santos, R. M.
(1994)
J. Biol. Chem.
269,
17095-17103
[Abstract/Free Full Text]
-
Sturgess, N. C., Hales, C. N., and Ashford, M. L. J.
(1986)
FEBS Lett.
208,
397-400
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sturgess, N. C., Hales, C. N., and Ashford, M. L. J.
(1987)
Pflugers Arch.
409,
607-615
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lebrun, P., Hermann, M., Yasumoto, T., and Herchuelz, A.
(1987)
Biochem. Biophys. Res. Commun.
144,
172-177
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rink, T. J.
(1990)
FEBS Lett.
268,
381-385
[CrossRef][Medline]
[Order article via Infotrieve]
-
Soergel, D. G., Yasumoto, T., Daly, J. W., and Gusovsky, F.
(1992)
Mol. Pharmacol.
41,
487-493
[Abstract]
-
Mason, M. J., Mayer, B., and Hymel, L. J.
(1993)
Am. J. Physiol.
264,
C654-C662
[Abstract/Free Full Text]
-
Lee, K.-M., Toscas, K., and Villereal, M. L.
(1993)
J. Biol. Chem.
268,
9945-9948
[Abstract/Free Full Text]
-
Poyer, J. F., Ryan, J. S., and Kelly, M. E. M.
(1996)
J. Membr. Biol.
153,
13-26
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dunne, M. J., Bullett, M. J., Li, G., Wollheim, C. B., and Petersen, O. H.
(1989)
EMBO J.
8,
413-420
[Medline]
[Order article via Infotrieve]
-
Ribalet, B., and Ciani, S.
(1994)
J. Membr. Biol.
142,
395-408
[Medline]
[Order article via Infotrieve]
-
Rasmussen, H., Isales, C. M., Calle, R., Throckmorton, D., Anderson, M., Gassalla-Herraiz, J., and McCarthy, R.
(1995)
Endocr. Rev.
16,
649-681
[Abstract/Free Full Text]
-
Henquin, J. C., Garcia, M. C., Bozem, M., Hermans, M. P., and Nenquin, M.
(1988)
Endocrinology
122,
2134-2142
[Abstract/Free Full Text]
-
Miura, Y., Gilon, P., and Henquin, J. C.
(1996)
Biochem. Biophys. Res. Commun.
224,
67-73
[CrossRef][Medline]
[Order article via Infotrieve]
-
Worley, J. F., III, McIntyre, M. S., Spencer, B., Mertz, R. J., Roe, M. W., and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
14359-14362
[Abstract/Free Full Text]
-
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y.
(1987)
J. Biol. Chem.
262,
5592-5595
[Abstract/Free Full Text]
-
Bischof, G., Illek, B., Reenstra, W. W., and Machen, T. E.
(1995)
Am. J. Physiol.
268,
C154-C161
[Abstract/Free Full Text]
-
Pfeiffer, F., Schmid, A., and Schulz, I.
(1995)
Pflugers Arch.
430,
916-922
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vostal, J. G., and Shafer, B.
(1996)
J. Biol. Chem.
271,
19524-19529
[Abstract/Free Full Text]
-
Maruyama, Y., and Petersen, O. H.
(1984)
J. Membr. Biol.
81,
83-87
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kinard, T. A., and Satin, L. S.
(1995)
Diabetes
44,
1461-1466
[Abstract]
-
Satin, L. S., Tavalin, S. J., Kinard, T. A., and Teague, J.
(1995)
Endocrinology
136,
4589-4601
[Abstract]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. A. Gault and C. Holscher
Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
J Neurophysiol,
April 1, 2008;
99(4):
1590 - 1595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev,
October 1, 2005;
85(4):
1303 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Cruz-Cruz, A. Salgado, C. Sanchez-Soto, L. Vaca, and M. Hiriart
Thapsigargin-sensitive cationic current leads to membrane depolarization, calcium entry, and insulin secretion in rat pancreatic {beta}-cells
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E439 - E445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miura and H. Matsui
Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic {beta}-cells
Am J Physiol Endocrinol Metab,
November 1, 2003;
285(5):
E1001 - E1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Eliasson, X. Ma, E. Renstrom, S. Barg, P.-O. Berggren, J. Galvanovskis, J. Gromada, X. Jing, I. Lundquist, A. Salehi, et al.
SUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells
J. Gen. Physiol.,
February 24, 2003;
121(3):
181 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamada, M. Komatsu, Y. Sato, K. Yamauchi, I. Kojima, T. Aizawa, and K. Hashizume
Time-Dependent Stimulation of Insulin Exocytosis by 3',5'-Cyclic Adenosine Monophosphate in the Rat Islet {beta}-Cell
Endocrinology,
November 1, 2002;
143(11):
4203 - 4209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Lawrence, H. S. Bhatt, and R. A. Easom
NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1
Diabetes,
March 1, 2002;
51(3):
691 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev.,
December 1, 1999;
20(6):
876 - 913.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. G. Holz, C. A. Leech, R. S. Heller, M. Castonguay, and J. F. Habener
cAMP-dependent Mobilization of Intracellular Ca2+ Stores by Activation of Ryanodine Receptors in Pancreatic beta -Cells. A Ca2+ SIGNALING SYSTEM STIMULATED BY THE INSULINOTROPIC HORMONE GLUCAGON-LIKE PEPTIDE-1-(7-37)
J. Biol. Chem.,
May 14, 1999;
274(20):
14147 - 14156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Straub, B. Kornreich, R. E. Oswald, E. F. Nemeth, and G. W. G. Sharp
The Calcimimetic R-467 Potentiates Insulin Secretion in Pancreatic beta Cells by Activation of a Nonspecific Cation Channel
J. Biol. Chem.,
June 16, 2000;
275(25):
18777 - 18784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ma, S. Ramanadham, M. Wohltmann, A. Bohrer, F.-F. Hsu, and J. Turk
Studies of Insulin Secretory Responses and of Arachidonic Acid Incorporation into Phospholipids of Stably Transfected Insulinoma Cells That Overexpress Group VIA Phospholipase A2 (iPLA2beta ) Indicate a Signaling Rather Than a Housekeeping Role for iPLA2beta
J. Biol. Chem.,
April 13, 2001;
276(16):
13198 - 13208.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|